Table 1.
IL-10 | TGF-β |
---|---|
Inhibits antigen present cell (APC) maturation, antigen presentation and pro-inflammatory cytokine secretion (58) Induces IL-10-producing DCs (59) |
Inhibits DC maturation and antigen presentation; promotes Langerhans cell development (60, 61) Stimulates cells at the resting state (monocytes), whereas activated cells (macrophages) are inhibited (62) |
Inhibits mast cell activation and release of pro-inflammatory cytokines (63) Inhibits eosinophil and basophil cytokine production (5) Suppresses ILC2 activation and cytokine production (64) |
Inhibits expression of FcϵRI (65) Promotes chemotaxis of neutrophils, eosinophils, and mast cells (66–68) |
Suppresses allergen-specific Teffs (69) | Suppresses allergen-specific Teffs (70, 71) Associates with CTLA-4 expression on T cells (72) Promotes T cell survival (73) |
Suppresses IgE (74) Induces IgG4 and IgA (75) |
Suppresses class switching to the majority of IgG isotypes (76, 77) Suppresses IgE (78) Induces IgA (79) |
Enhances B cell survival (75, 80) | Inhibits B cell proliferation (81) Promotes apoptosis of naïve or immature B cells (82, 83) |
Promotes the generation of Tr1 cells (84) | Induces Foxp3 and suppressive function of Tregs (72, 85) Induces Th9, Th17 and Tfh cells under different conditions (86–88) |
Synergistic effect in in vivo suppression with CTLA-4, PD-1 and TGF-β (89) | Synergistic effect in in vivo suppression with CTLA-4, PD-1 and IL-10 (89) |